Press release
Anti-inflammatory Therapeutics Market: USD 94.6 Bn Value in 2022, Rising at 5.1% CAGR to USD 149.5 Bn by 2031 - TMR Insights
Anti-inflammatory Therapeutics
The anti-inflammatory therapeutics industry was valued at US$ 94.6 billion in 2022 and is projected to expand at a CAGR of 5.1% from 2023 to 2031. By the end of 2031, the market is anticipated to surpass US$ 149.5 billion. This growth is fueled by advancements in biologics, the introduction of novel small molecules, and an increasing focus on precision medicine.
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1907
Analyst Viewpoint
Analysts highlight the significant role of biologics and biosimilars in transforming the anti-inflammatory therapeutics landscape. The market is expected to witness robust growth due to the rising adoption of targeted therapies, which offer enhanced efficacy with reduced side effects. However, high drug development costs and stringent regulatory approvals pose challenges to market expansion.
Key Market Drivers
Rising Prevalence of Chronic Diseases - Conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis are contributing to the growing demand for anti-inflammatory drugs.
Advancements in Biologic Therapies - Biologic drugs, including monoclonal antibodies, are revolutionizing treatment approaches, leading to better patient outcomes.
Growing Geriatric Population - Elderly individuals are more prone to inflammatory conditions, boosting market demand.
Increased Investment in Drug Development - Pharmaceutical companies are investing heavily in R&D to develop innovative therapies with improved efficacy.
Government Initiatives and Healthcare Policies - Supportive regulatory frameworks and healthcare policies are encouraging market growth.
Recent Developments
Expansion of Biologic Drug Portfolios - Leading pharmaceutical companies are expanding their biologic and biosimilar product lines to cater to the growing demand.
Strategic Collaborations and Acquisitions - Mergers and acquisitions among key players are fostering innovation and strengthening market presence.
Introduction of Novel Small Molecules - Research in small molecule inhibitors has led to the development of new therapeutic options.
Key Players
AbbVie, Inc.
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Novartis AG
GlaxoSmithKline plc.
Amgen, Inc.
F. Hoffmann-La Roche Ltd.
AstraZeneca
Sanofi
Visit our report to discover essential insights and analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1907
Market Trends and Opportunities
The anti-inflammatory therapeutics market is evolving with a growing focus on personalized medicine, which enhances treatment effectiveness while minimizing side effects. Increasing approvals of biosimilars are making treatments more affordable, expanding patient access worldwide. The demand for novel drug delivery systems, including nanoparticles and targeted therapies, is also on the rise. Additionally, the shift toward natural and plant-based anti-inflammatory solutions is gaining traction, reflecting consumer preferences for alternative treatments. Emerging economies in Asia-Pacific and Latin America offer substantial growth opportunities due to rising healthcare investments and an increasing prevalence of inflammatory diseases.
Market Segmentation
By Drug Class
Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Corticosteroids
Biologics
Small Molecule Drugs
By Indication
Rheumatoid Arthritis
Psoriasis
Inflammatory Bowel Disease (IBD)
Multiple Sclerosis
Other Autoimmune Disorders
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Future Outlook
The anti-inflammatory therapeutics market is expected to witness sustained growth, driven by continuous advancements in drug development and increasing healthcare expenditure. The emphasis on biologics, biosimilars, and precision medicine will remain pivotal in shaping the future of the industry. Additionally, market players are likely to focus on cost-effective treatment solutions to enhance patient accessibility.
Regional Analysis
North America - Dominates the market due to high adoption rates of biologics and robust healthcare infrastructure.
Europe - Witnesses significant growth, driven by an aging population and government support for drug innovation.
Asia-Pacific - Expected to register the fastest growth, fueled by increasing healthcare investments and rising disease burden.
Latin America & Middle East & Africa - Emerging markets with growing demand for affordable anti-inflammatory treatments.
Explore Latest Research Reports by Transparency Market Research:
Healthcare Biometrics Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-biometrics-market-to-surpass-us-7408-billion-by-2035-driven-by-advancements-in-security-digital-health-solutions-tmr-insights
Healthcare Contract Research Outsourcing Market: https://www.pharmiweb.com/press-release/2025-03-12/healthcare-contract-research-outsourcing-market-to-surpass-us-6309-billion-by-2035-driven-by-increasing-demand-for-cost-effective-drug-development
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-inflammatory Therapeutics Market: USD 94.6 Bn Value in 2022, Rising at 5.1% CAGR to USD 149.5 Bn by 2031 - TMR Insights here
News-ID: 3943484 • Views: …
More Releases from Transparency Market Research
Global GLP-1 Analogues Market Poised for Transformational Growth, Projected to R …
The global GLP-1 analogues market is entering a phase of unprecedented expansion, driven by the rising burden of type 2 diabetes and obesity, rapid innovation in drug formulations, and growing recognition of the cardiometabolic benefits of GLP-1-based therapies. According to the latest industry outlook, the market was valued at US$ 51.6 billion in 2024 and is projected to reach US$ 211.8 billion by 2035, registering a robust compound annual growth…
Flow Chemistry Market to be Worth USD 5.9 Bn by 2035 - By Reactor Scale / By Rea …
The global Flow Chemistry Market was valued at US$ 2.1 Billion in 2024 and is projected to reach US$ 5.9 Billion by 2035, expanding at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2035. This strong growth trajectory reflects the increasing adoption of continuous manufacturing technologies across pharmaceuticals, fine and specialty chemicals, agrochemicals, and performance materials.
Explore core findings and critical insights from our Report in this sample…
Medical Simulation Market to See Breakthrough Growth, Approaching USD 13.1 Billi …
The medical simulation market has emerged as a critical pillar of modern healthcare education and training. Medical simulation refers to the use of advanced technologies such as manikins, virtual reality, augmented reality, task trainers, and software platforms to replicate real-world clinical scenarios in a controlled environment. These tools allow healthcare professionals to practice procedures, improve decision-making skills, and enhance teamwork without risking patient safety. As healthcare systems worldwide move toward…
Building Automation and Control System Market Outlook 2035: Expanding from US$ 1 …
The global building automation and control system (BACS) market is entering a decade of sustained expansion as digitalization, energy efficiency mandates, and smart infrastructure investments reshape the built environment. Valued at US$ 100.6 billion in 2024, the market is projected to reach US$ 230.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 7.8% from 2025 to 2035. This growth reflects the accelerating adoption of intelligent systems…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
